Search
+
    SEARCHED FOR:

    MADHUSUDAN KELA

    Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?

    Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Compared to Novo Nordisk's Ozempic, Zaynich’s $25 billion potential counters global antibiotic resistance.

    Wockhardt shares hit 5% upper circuit after Prashant Jain, Madhusudan Kela and others invest in QIP

    3P India Equity Fund, managed by Prashant Jain, and Madhusudan Kela's Cohesion MK Best Ideas sub-trust are among those funds that have received 5% or more shares in the Qualified Institutional Placement (QIP) of shares.

    AM Naik, Madhusudan Kela to back medical devices maker S3V Vascular Technologies

    S3V Vascular Technologies Limited, a medical devices manufacturing company based in Mysore, has raised approximately Rs 300 crore from investors including former L&T chairman AM Naik and industry veteran Madhusudan Kela. This Series B funding will be used to establish a state-of-the-art integrated manufacturing facility worth Rs 300 crore for neurovascular devices, aiming to address the rise of strokes in India.

    Ace investor Madhusudan Kela caught in deepfake scare

    Madhusudan Kela clarified that there are no such claims made and he doesn't support these communications. Kela vowed legal action against the video in due course. Kela further appealed to investors to not invest based on any such videos.

    Madhu Kela-backed Rashi Peripherals announces IPO price band. Check details

    Rashi Peripherals IPO is entirely a fresh equity issue of Rs 600 crore with no offer-for-sale component. About 50% of the issue is reserved for qualified institutional buyers, 15% for non-institutional bidders, and 35% for retail investors.

    Madhuri Madhusudan Kela-backed Rashi Peripherals IPO to open on Feb 7. Check details

    The initial public offer (IPO) of IT solutions company Rashi Peripherals will open for subscription on February 7 and close on February 9. The allocation to anchor investors will be done a day ahead of the issue opening on February 6. The company had filed draft papers for its IPO last year.

    The Economic Times
    BACK TO TOP